The results showed that inhibiting the expression of RHOT1 and RAC1 in Lv-HMGB1 PLC cells could reduce the mitochondrial transfer, the migration and invasion ability of HCC cells, and the in vivo tail vein lung metastasis ability (Fig. 6k–o). The gene discussed is HMGB1; the disease is hepatocellular carcinoma.